
SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Health officials report 14 Legionnaires' disease cases in Florida, gym connection suspected - 2
Netanyahu on Gush Etzion terror attack: 'We will complete war on all fronts' - 3
How to identify animal tracks, burrows and other signs of wildlife in your neighborhood - 4
The Main 20 Gaming Control center Ever - 5
Compassion and Association: Building Significant Connections
Higher cost, worse coverage: Affordable Care Act enrollees say expiring subsidies will hit them hard
Figure out How to Get a good deal on Your Rooftop Substitution Venture
Strengthening through Wellness: Individual Preparation Achievement
Vote In favor of Your Favored Keeping an eye on
Ukraine Now Using Drone Boats To Attack Russian Riverine Targets
The Benefits of Effective money management for Your Youngsters' Future Monetary Prosperity
Nestlé recalls infant formula in 49 countries. See list.
Winter solstice 2025 marks the shortest day of the year in the Northern Hemisphere today
Recent studies prove the ancient practice of nasal irrigation is effective at fighting the common cold













